AQP4 and myeloid sarcoma: Therefore, in this study, we evaluated the total and differential WBC counts in patients with these diseases and compared them with counts in matched volunteers or patients with MS to understand the abnormalities and characteristics of WBC count profiles in AQP4-IgG-positive NMOSD and MOGAD.